In another study focusing on the anti-tumor potential of T cell-derived EVs, miRNAs such as miR-25–3p, miR-155–5p, miR-215–5p, and miR-375 were found to be enriched in EVs secreted from IL-2-stimulated CD4+ T cells [21]. The gene discussed is CD4; the disease is neoplasm.